Gerard Platenburg PhD

Gerard Platenburg is our co-founder and has served as our Chief Scientific Officer since 2022, following his tenure as our Chief Innovation Officer from 2014 to 2022, and joined our board as an executive director in May 2024. Gerard has an extensive background in RNA modulation and orphan drug discovery and development, and is currently in charge of our R&D. Gerard has more than 25 years of senior managerial experience in growing biotech companies. Before joining our company, Gerard worked at Isa Pharmaceuticals B.V. as its Chief Executive Officer.

Gerard co-founded Prosensa Holding N.V., growing it to become a well-known clinical-stage RNA modulation company, and held various positions during his tenure, including as its Chief Executive Officer and Chief Development Officer. Gerard also worked at Pharming B.V. Gerard is a passionate and driven pioneer of early-stage technologies. Gerard has a master’s degree in Chemistry and Molecular Biology from Leiden University and a Ph.D. from Leiden University.